Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).
托珠单抗治疗 COVID-19 肺炎住院患者:一项随机对照试验的疗效、安全性、病毒清除率和抗体反应 (COVACTA)
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101409
Rosas Ivan O, Bräu Norbert, Waters Michael, Go Ronaldo C, Malhotra Atul, Hunter Bradley D, Bhagani Sanjay, Skiest Daniel, Savic Sinisa, Douglas Ivor S, Garcia-Diaz Julia, Aziz Mariam S, Cooper Nichola, Youngstein Taryn, Sorbo Lorenzo Del, Zerda David J De La, Ustianowski Andrew, Gracian Antonio Cubillo, Blyth Kevin G, Carratalà Jordi, François Bruno, Benfield Thomas, Haslem Derrick, Bonfanti Paolo, van der Leest Cor H, Rohatgi Nidhi, Wiese Lothar, Luyt Charles Edouard, Bauer Rebecca N, Cai Fang, Lee Ivan T, Matharu Balpreet, Metcalf Louis, Wildum Steffen, Graham Emily, Tsai Larry, Bao Min